Canadian application, no grantCanada
The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
CA 2474855 A1 · Owner: Wurtz, Jean-Marie · Inventors: Wurtz, Jean-Marie; Moras, Dino; Renaud, Jean-Paul
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the identification of novel biologically active compounds having an agonist or an antagonist effect on the transcriptional-activating activity of the Estrogen-Related Receptor 3 (ERR3).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 30, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 30, 2003
GrantedNo grant recorded
Term endedJanuary 30, 2023
Patent numberCA 2474855 A1
Classification (IPC)G01N33/50 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.